clopidogrel and Carcinoma, Anaplastic

clopidogrel has been researched along with Carcinoma, Anaplastic in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's3 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Edogawa, S; Harada, S; Higuchi, K; Kojima, Y; Ota, K; Takeuchi, T; Tokioka, S; Umegaki, E1
Collins, L; Conley, PB; Craft, CS; Deng, H; Eagleton, MC; Floyd, DH; Grabowska, D; Heller, E; Hirbe, AC; Hughes, A; Hurchla, MA; Novack, DV; Piwnica-Worms, D; Rogers, M; Schneider, JG; Steinberg, TH; Su, X; Townsley, S; Uluckan, O; Weilbaecher, KN; Wu, K; Xiang, J; Zou, W1
Can, MM; Dinicolantonio, JJ; Goto, S; Serebruany, VL1

Other Studies

3 other study(ies) available for clopidogrel and Carcinoma, Anaplastic

ArticleYear
The postoperative bleeding rate and its risk factors in patients on antithrombotic therapy who undergo gastric endoscopic submucosal dissection.
    BMC gastroenterology, 2013, Sep-06, Volume: 13

    Topics: Adenoma; Aged; Anti-Ulcer Agents; Anticoagulants; Aspirin; Carcinoma; Case-Control Studies; Clopidogrel; Dissection; Female; Gastric Mucosa; Gastrointestinal Hemorrhage; Gastroscopy; Humans; Logistic Models; Male; Middle Aged; Odds Ratio; Platelet Aggregation Inhibitors; Postoperative Hemorrhage; Proton Pump Inhibitors; Retrospective Studies; Risk Factors; Stomach Diseases; Stomach Neoplasms; Stomach Ulcer; Thienopyridines; Ticlopidine; Warfarin

2013
The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling.
    The Journal of clinical investigation, 2012, Volume: 122, Issue:10

    Topics: Adenosine Diphosphate; Animals; Arthritis, Experimental; Bone Neoplasms; Bone Remodeling; Bone Resorption; Carcinoma; Cell Adhesion; Cells, Cultured; Clopidogrel; Enzyme Activation; Female; Mammary Neoplasms, Experimental; Mice; Mice, Inbred C57BL; Mice, Knockout; Osteoclasts; Osteoporosis; Ovariectomy; Phosphatidylinositol 3-Kinases; Phosphoinositide-3 Kinase Inhibitors; Platelet Glycoprotein GPIIb-IIIa Complex; Purinergic P2Y Receptor Antagonists; rap1 GTP-Binding Proteins; Receptors, Purinergic P2Y12; Specific Pathogen-Free Organisms; Ticlopidine

2012
Unclassified pleomorphic and spindle cell pulmonary neoplasm with brain metastases after prasugrel.
    Cardiology, 2013, Volume: 124, Issue:2

    Topics: Aged; Aspirin; Brain Neoplasms; Carcinoma; Clinical Trials, Phase III as Topic; Clopidogrel; Colonic Neoplasms; Coronary Stenosis; Diabetes Mellitus, Type 1; Diabetic Cardiomyopathies; Drug Therapy, Combination; Drug-Eluting Stents; Fatal Outcome; Female; Humans; Lung Neoplasms; Piperazines; Platelet Aggregation Inhibitors; Prasugrel Hydrochloride; Purinergic P2Y Receptor Antagonists; Randomized Controlled Trials as Topic; Risk Factors; Thiophenes; Ticlopidine; Time Factors

2013